Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
PaperCitations, authors & open-access status
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 322 citations, 2021 year and bronze oa status.
322
Citations
2021
Year
bronze
OA Status